Special Drug Use-Results Survey of Onoact
Not Applicable
Completed
- Conditions
- tachyarrhythmia, atrial fibrillation/atrial flutter in patients with cardiac dysfunction
- Registration Number
- JPRN-jRCT1080222572
- Lead Sponsor
- ONO PHARMACEUTICAL CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 800
Inclusion Criteria
Patients with tachyarrhythmia, atrial fibrillation/atrial flutter under cardiac dysfunction for whom Onoact is administered
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety<br>Safety items : Occurrence status of adverse events (including adverse drug reactions)
- Secondary Outcome Measures
Name Time Method safety<br>Prognosis untill 180days after Onoact treatment suc as mortality and cardiovascular events